Skip to main navigation Skip to search Skip to main content

Engineering the future of cancer nanomedicine: From rational design to clinical translation

  • Xi Hu
  • , Han Lin
  • , Li Ma
  • , Zhong Guo
  • , Mingzhen Zhang
  • , Yang Zhu
  • , Fangfang Chen
  • , Wei Jiang
  • , Xudong Shi
  • , Jiuyang He
  • , Kelong Fan
  • , Xiaoping Chen
  • Anhui University of Chinese Medicine
  • CAS - Shanghai Institute of Ceramics
  • Jinan University
  • Beijing Normal University
  • Fujian Medical University
  • Jilin University
  • Zhengzhou University
  • Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College
  • Beijing Institute of Technology
  • CAS - Institute of Biophysics
  • Zhongyuan Nanozyme Laboratory
  • Huazhong University of Science and Technology

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalOncology and Translational Medicine
DOIs
StateAccepted/In press - 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this